Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate (FAST)

This study has been completed.
Biocompatibles UK Ltd
Information provided by (Responsible Party):
Juanita Crook, British Columbia Cancer Agency Identifier:
First received: July 30, 2010
Last updated: February 8, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)